Versantis is a Swiss pharmaceutical company developing new generations of liver disease medicines and diagnostics addressing high unmet medical needs.
Zurich, Switzerland
Joined March 2017
- Tweets109
- Following57
- Followers146
- Likes82
Versantis retweeted
Versantis' lead molecule has received a Rare Pediatric Diseases Designation from the U.S. FDA and an Orphan Drug Designation from EMA. Now U.S. Food and Drug Administration has also granted Versantis orphan drug designation to VS-01. startupticker.ch/en/news/u-s…
Versantis retweeted
La #biotech zurichoise @VersantisAG annonce que son traitement phare VS-01 a obtenu le statut de médicament orphelin de la part des autorités américaines ⬇ agefi.com/actualites/entrepr…
Versantis retweeted
Complications of having a urea cycle disorder:
When a person has too much ammonia in their blood (hyperammonemia), it can cause them to have a serious complication called a hyperammonemic crisis.
#UCD #UreaCycleDisorder #UreaCycle raremark.com/urea-cycle-diso…
Versantis retweeted
"The most rewarding aspect of being a founder is to start writing the story of your startup on a blank page"
Meriam Kabbaj, COO of TOP 100 Swiss Startup @VersantisAG, reflecting on routines, books, family, and more.
Get inspired: venturelab.ch/Versantis-COO-…
#SwissStartups #TOP100SSU
Versantis retweeted
The TOP 100 Swiss Startup Award ranking has become a benchmark in Switzerland’s startup ecosystem.
Proud to present to you the top startups in biotech: @AGCutiss, @VersantisAG, @Resistell_ & @KetoSwiss
venturelab.ch/Switzerlands-T…
#TOP100SSU #10xTOP100 #SwissStartups #Biotech
Versantis retweeted
“This is the first drug to use a disruptive route to enhance the clearance of ammonia and other toxins from the body.” #biotech #liverdisease @VersantisAG
bit.ly/32TwcKl
Versantis retweeted
Great news: @VersantisAG, our very first #MCCH16 edition Diamond Winner, just closed CHF 16M Series B financing round to advance clinical development of novel therapeutics for liver disease . Congrats! 👏🏻
More details 👉 versantis.ch/achievements.ph…
#MCCH #changemakers
Versantis retweeted
@VersantisAG has raised money in order to advance its liver detoxifying candidate VS-01 from ongoing Phase Ia trials to initial Phase IIa efficacy proof. #liverfunction #financing
european-biotechnology.com/u…
Versantis retweeted
La #biotech zurichoise @VersantisAG a bouclé une ronde de financement de 16 millions de francs ➡ ow.ly/O06p50weJIX
Versantis retweeted
Applause for @VersantisAG 👏👏👏 the biotech company announced the successful completion of their #SeriesB! 💰
More on our blog: ow.ly/nD3N50weQNg
#EmpoweringGameChangers
Versantis retweeted
Swiss biotech raises $16M to test 'undelivery mechanism' for rare liver disease endpts.com/swiss-biotech-rai…
Versantis retweeted
SCIENCE NEVER RESTS/ following approval by German regulatory authorities (BfArM), we are happy to announce that our portfolio company @VersantisAG has successfully reached FIRST-IN-HUMAN this August, officially starting a Phase 1b... such an important milestone! so proud of you!
Versantis retweeted
Cirrhosis deaths: more action is needed now - Health Awareness healthawareness.co.uk/gut-he…
Versantis retweeted
As a rare disease, #UreaCycleDisorder (UCD) affects about 1 in 35,000 births in the U.S. Find more to understand UCD bit.ly/2wFiRcl
Versantis retweeted
#TimesSquare sugar dump shows how much added #sugar American children consume every 5 minutes! usat.ly/2iI7B9h #NAFLD @KINDSnacks -
Versantis retweeted
[In press] Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with #cirrhosis
bit.ly/2vFjXUb
#ACLF
Versantis retweeted
From @AJPathology: Chronic liver inflammation linked to Western diet medicalnewstoday.com/release… #cirrhosis #WesternDiet
Versantis retweeted
[Correspondence] Serum metabolic signatures in patients with overt #hepatic #encephalopathy
bit.ly/2uxcJ1K
Versantis retweeted
RIP: 'True Blood' Actor Nelsan Ellis Died Due to Alcohol Withdrawal Complications, Family Says: Hollywood Reporter - bit.ly/2tHfWf7